传统探针小梁切开术与微导管辅助360°小梁切开术(PIRATE)治疗儿童青光眼:随机对照试验研究方案
这项前瞻性、多中心、观察者设盲的随机对照试验拟纳入76名(152眼)≤12岁双侧原发性或继发性儿童青光眼患儿,采用配对眼设计,一眼行微导管辅助360°小梁切开术(MCAT),另一眼行传统探针小梁切开术(90–120°),随访24个月,主要终点为24个月完全成功(眼压<18 mmHg且未用药、未行修正手术;MCAT组还需成功探通>120°)。
要点
- PIRATE研究采用配对眼设计比较MCAT与传统探针小梁切开术在儿童青光眼中的成功与安全性。
- 计划纳入76名(152眼)≤12岁双侧原发性或继发性儿童青光眼患儿。
- 主要终点为24个月完全成功:眼压<18 mmHg且未用药、未行修正手术,MCAT组还需成功探通>120°。
核心结论
- 该研究将提供MCAT与传统探针小梁切开术的成功与安全性数据,并明确MCAT是否优于探针小梁切开术。
研究设计与样本
- 前瞻性、多中心、观察者设盲、随机对照试验,计划纳入76名(152眼)≤12岁双侧原发性或继发性儿童青光眼患儿。
- 采用配对眼设计,每名患儿一眼分配至MCAT(实验干预,实现360°小梁切开),另一眼分配至探针小梁切开术(对照干预,实现90–120°小梁切开),每名患儿接受两种手术,先治疗较差眼,手术方法随机分配。
- 患者和观察者设盲,随访24个月,主要分析在意向治疗人群中使用按中心分层的McNemar检验。
关键数值与推荐
- 主要终点为随访24个月时的完全成功:眼压<18 mmHg且未使用药物、未行修正手术;MCAT组还需成功探通>120°方为成功。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare the success and safety of microcatheter-assisted 360° trabeculotomy (MCAT) with conventional probe trabeculotomy in a large, heterogeneous cohort of children with primary or secondary glaucoma. METHODS: In this prospective, multicenter, observer-blinded, randomized controlled trial, 76 children (152 eyes) with bilateral primary or secondary childhood glaucoma aged ≤ 12 years will be included. Each child acts as own control using a paired-eye design: One eye is allocated to MCAT (experimental intervention), achieving a 360° trabeculotomy, the other eye to the probe trabeculotomy (control intervention) which enables a trabeculotomy over 90 to 120°. Each child receives both procedures (paired-eye design). The worse eye is treated first; the surgical method is randomized. Patients and observers are masked to the procedures. The patients are followed up for 24 months. The primary endpoint is complete success (IOP < 18 mmHg at 24 months without medication and revision surgery; with MCAT: successful probing of > 120° is also required for success) at 24 months of follow-up. The primary analysis is performed in the intention-to-treat population using McNemar test stratified by center. DISCUSSION: The PIRATE study is a multicenter randomized controlled study comparing MCAT with conventional probe trabeculotomy in a large and heterogeneous childhood glaucoma population. It will provide data on the success and safety of both techniques and clarify if MCAT is superior to probe trabeculotomy. TRIAL REGISTRATION: German Clinical Trials Register, DRKS-ID: DRKS00034139. Registered on April 24, 2024. https://drks.de/search/en/trial/DRKS00034139 . https://trialsearch.who.int/Trial2.aspx?TrialID=DRKS00034139 .
引用
- Stingl JV, Schmidtmann IM, Schepers M, et al. Conventional probe trabeculotomy versus microcatheter-assisted 360° trabeculotomy (PIRATE) in childhood glaucoma-study protocol for a randomized controlled trial. Trials. 2025. PMID: 40983930. doi:10.1186/s13063-025-09091-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。